Jun 15, 2018 by Brian Orelli, PhDWhy Verastem Stock Rocketed Higher TodayA rate secondary offering with no discount gives investors the confidence to hit the buy button.
Jun 14, 2018 by Brian Orelli, PhDHere's Why Cara Therapeutics Jumped 26.3% in MayThe biotech signed a big partnership to cap off the month.
Jun 14, 2018 by Brian Orelli, PhDWhy Marijuana Stock GW Pharmaceuticals Gained 21% in MayThe biotech has an FDA decision pending on its epilepsy drug.
Jun 12, 2018 by Brian Orelli, PhDHere's Why Kadmon Shot Higher TodayInvestors are excited about the biotech's new infusion of cash.
Jun 12, 2018 by Brian Orelli, PhDHere's Why Aurinia Pharmaceuticals Inc. Jumped 11% in MayInvestors are excited about the potential for its lead drug to expand into additional diseases.
Jun 7, 2018 by Brian Orelli, PhDHere's Why ImmunoGen Inc. Fell 9.2% TodayA secondary offering will dilute investors.
Jun 6, 2018 by Brian Orelli, PhDWhy Endo International plc Rocketed Higher TodayTraders take the generic-drug maker on a ride.
Jun 4, 2018 by Brian Orelli, PhDHere's Why Genomic Health Rocketed Higher TodayNew data shows the usefulness of the company's breast cancer test.
Jun 1, 2018 by Brian Orelli, PhDCantel Medical Takes Its Foot off the GasCapital spending by its customers slows revenue growth.
May 31, 2018 by Brian Orelli, PhDWhy ImmunoGen Jumped Higher TodayInvestors are looking forward to the biotech's presentation at ASCO.
May 31, 2018 by Brian Orelli, PhDASCO Conference Preview: Here's What Biotech Investors Need to WatchThe biggest cancer meeting of the year is upon us, with updates on clinical trials.
May 31, 2018 by Brian Orelli, PhDClearside Biomedical Stock Down 26%: The "Positive" Data That Wasn'tSometimes press release headlines and share prices don't match up.
May 23, 2018 by Brian Orelli, PhDWhy Ardelyx Inc. Is Down by Double Digits for a Second Day in a RowThe buyers for its secondary stock offering weren't willing to pay up for the biotech.
May 22, 2018 by Brian Orelli, PhDHere's Why Tiny Biotech Ardelyx Saw a Big Decline TodayThe stock is down almost 20% after the company announced it was raising cash two different ways.
May 18, 2018 by Brian Orelli, PhDHere's Why Abeona Therapeutics Stock Dropped 12% TodayA clinical trial update for AB-102 didn't go far enough.
May 18, 2018 by Brian Orelli, PhDWinners and Losers From the Biggest Cancer Meeting of the Year (So Far)The meeting hasn't even started, and stocks are already moving.
May 17, 2018 by Brian Orelli, PhDWhy Endocyte Stock Jumped Higher TodayInvestors are excited about updated data from a phase 2 trial of its prostate cancer drug.
May 16, 2018 by Brian Orelli, PhDWhy Verastem Stock Is Plunging TodayThe biotech is raising cash ahead of a potential launch of its first drug.
May 15, 2018 by Brian Orelli, PhDDiplomat Pharmacy Integrates With New LeadershipIntegration of the new pharmacy benefit manager into the specialty pharmacy is proceeding well, with a new CEO to lead the way from here.
May 15, 2018 by Brian Orelli, PhDMomenta Pharmaceuticals Contemplates Its FutureThe company is undergoing a strategic review to determine its priorities.
